Saltar al contenido
Merck

New polyphenols active on beta-amyloid aggregation.

Bioorganic & medicinal chemistry letters (2007-11-29)
Céline Rivière, Tristan Richard, Xavier Vitrac, Jean-Michel Mérillon, Josep Valls, Jean-Pierre Monti
RESUMEN

New polyphenol classes have been tested against amyloid-beta peptide aggregation. We have identified four novel polyphenols which could be efficient fibril inhibitors in Alzheimer's disease: malvidin and its glucoside and curculigosides B and D. We suggest that molecules with the particular C(6)-linkers-C(6) structure could be potent inhibitors. From the results reported for the flavan-3-ol family, their anti-amyloidogenic effects against whole peptides (1-40 and 1-42) could involve several binding sites.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Resveratrol, ≥99% (HPLC)
Sigma-Aldrich
Caffeic acid, ≥98.0% (HPLC)
Sigma-Aldrich
4-Hydroxybenzoic acid, ReagentPlus®, ≥99%
Sigma-Aldrich
4-Hydroxybenzoic acid, ReagentPlus®, 99%
Sigma-Aldrich
p-Coumaric acid, ≥98.0% (HPLC)
Sigma-Aldrich
(−)-Epigallocatechin gallate, ≥95%
Sigma-Aldrich
(−)-Epigallocatechin gallate, ≥80% (HPLC), from green tea
Sigma-Aldrich
(−)-Epicatechin gallate, ≥98% (HPLC), from green tea
Sigma-Aldrich
(−)-Epigallocatechin, ≥95% (HPLC), from green tea
Supelco
Resveratrol, analytical standard
Supelco
Caffeic acid, matrix substance for MALDI-MS, ≥99.0% (HPLC)
Supelco
(−)-Epigallocatechin, analytical standard